278 related articles for article (PubMed ID: 30498175)
1. Evaluation of Serum Desmoglein 1 and Desmoglein 3 in Oral Erosive Lichen Planus before and after Topical Application of Tacrolimus.
Saad I; Salem S
J Contemp Dent Pract; 2018 Oct; 19(10):1204-1213. PubMed ID: 30498175
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies to desmogleins 1 and 3 in patients with lichen planus.
Vahide L; Zahra H; Forugh G; Nazi S
Arch Dermatol Res; 2017 Sep; 309(7):579-583. PubMed ID: 28674915
[TBL] [Abstract][Full Text] [Related]
3. Serum autoantibodies to desmogleins 1 and 3 in patients with oral lichen planus.
Lukac J; Brozović S; Vucicević-Boras V; Mravak-Stipetić M; Malenica B; Kusić Z
Croat Med J; 2006 Feb; 47(1):53-8. PubMed ID: 16489697
[TBL] [Abstract][Full Text] [Related]
4. Two cases of erosive oral lichen planus with autoantibodies to desmoglein 3.
Muramatsu K; Nishie W; Natsuga K; Fujita Y; Iwata H; Yamada T; Yamashita E; Asaka T; Shimizu H
J Dermatol; 2016 Nov; 43(11):1350-1353. PubMed ID: 27458049
[TBL] [Abstract][Full Text] [Related]
5. [Detection of serum desmoglein antibody level using enzyme-linked immunosorbent assay (ELISA) for monitoring disease activity in patients with pemphigus vulgaris].
Zhong S; Qiu YF; Han BB; Zhao JY; Zhu XJ; Chen XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 43(3):414-5. PubMed ID: 21681274
[TBL] [Abstract][Full Text] [Related]
6. Oral lichen planus with antibodies to desmogleins 1 and 3.
Kinjyo C; Kaneko T; Korekawa A; Rokunohe A; Aizu T; Matsuzaki Y; Nakano H; Sawamura D
J Dermatol; 2015 Jan; 42(1):40-1. PubMed ID: 25354571
[TBL] [Abstract][Full Text] [Related]
7. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay.
Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T
Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273
[TBL] [Abstract][Full Text] [Related]
8. An open trial of topical tacrolimus for erosive oral lichen planus.
Morrison L; Kratochvil FJ; Gorman A
J Am Acad Dermatol; 2002 Oct; 47(4):617-20. PubMed ID: 12271312
[TBL] [Abstract][Full Text] [Related]
9. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus.
Kaliakatsou F; Hodgson TA; Lewsey JD; Hegarty AM; Murphy AG; Porter SR
J Am Acad Dermatol; 2002 Jan; 46(1):35-41. PubMed ID: 11756943
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of topical tacrolimus in the management of ulcerative/erosive oral lichen planus.
Hodgson TA; Sahni N; Kaliakatsou F; Buchanan JA; Porter SR
Eur J Dermatol; 2003; 13(5):466-70. PubMed ID: 14693491
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study.
Olivier V; Lacour JP; Mousnier A; Garraffo R; Monteil RA; Ortonne JP
Arch Dermatol; 2002 Oct; 138(10):1335-8. PubMed ID: 12374539
[TBL] [Abstract][Full Text] [Related]
12. Refractory erosive oral lichen planus associated with hepatitis C: response to topical tacrolimus ointment.
Donovan JC; Hayes RC; Burgess K; Leong IT; Rosen CF
J Cutan Med Surg; 2005 Apr; 9(2):43-6. PubMed ID: 16392010
[TBL] [Abstract][Full Text] [Related]
13. Desmoglein 1 and 3 enzyme-linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity.
Daneshpazhooh M; Chams-Davatchi C; Khamesipour A; Mansoori P; Taheri A; Firooz A; Mortazavi H; Esmaili N; Dowlati Y
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1319-24. PubMed ID: 17958835
[TBL] [Abstract][Full Text] [Related]
14. Salivary and Serum Anti-Desmoglein 1 and 3 ELISA and Indirect Immunofluorescence in Pemphigus Vulgaris: Correlations with Serum ELISA, Indirect Immunofluorescence and Disease Severity.
Koopai M; Mortazavi H; Khatami A; Khodashenas Z
Acta Dermatovenerol Croat; 2018 Jun; 26(2):91-99. PubMed ID: 29989863
[TBL] [Abstract][Full Text] [Related]
15. Response of oral lichen planus to topical tacrolimus in 37 patients.
Byrd JA; Davis MD; Bruce AJ; Drage LA; Rogers RS
Arch Dermatol; 2004 Dec; 140(12):1508-12. PubMed ID: 15611431
[TBL] [Abstract][Full Text] [Related]
16. Salivary Samples for the Diagnosis of Pemphigus vulgaris Using the BIOCHIP Approach: a Pilot Study.
Russo I; Saponeri A; Michelotto A; Alaibac M
In Vivo; 2017 Jan; 31(1):97-99. PubMed ID: 28064226
[TBL] [Abstract][Full Text] [Related]
17. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris.
De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW
Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318
[TBL] [Abstract][Full Text] [Related]
18. Treatment of erosive oral lichen planus with topical tacrolimus.
Thomson MA; Hamburger J; Stewart DG; Lewis HM
J Dermatolog Treat; 2004 Sep; 15(5):308-14. PubMed ID: 15370399
[TBL] [Abstract][Full Text] [Related]
19. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment.
Laeijendecker R; Tank B; Dekker SK; Neumann HA
Acta Derm Venereol; 2006; 86(3):227-9. PubMed ID: 16710580
[TBL] [Abstract][Full Text] [Related]
20. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity.
Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
